Semaglutide 2.4 mg
Semaglutide 2.4 mg is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
Clinical Trials (7)
Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7